Compare Rent the Runway Inc (RENT) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rent the Runway Inc vs Tango Therapeutics Inc. — how do they compare? Rent the Runway Inc trades at $1.71 (market cap $61.07M), while Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is far larger — about 61.4× Rent the Runway Inc's market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and Tango Therapeutics Inc. for 0 Days on average.
| RENT | TNGX | |
|---|---|---|
Market Cap | $61.07M | $3.75B |
Volume | 80,595 | 9,619,106 |
Sector | Consumer Cyclical | Health |
52-Week High | $9.39 | $32.90 |
52-Week Low | $1.55 | $7.50 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $228.07M | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rent the Runway (RENT) trades at $1.71, down 6.56% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported revenue of $306.20M in 2025 with a gross margin of 74.73%, though net income was -$69.90M. Recent news includes a CEO appointment and multiple law firm investigations into investor claims.
The outlook remains challenging with negative equity and high debt, but improving margins and projected 2026 profitability offer potential. Risks include legal scrutiny and financial leverage, while analyst consensus is cautiously optimistic with 42% buy ratings. Stock performance hinges on execution of turnaround efforts.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
